gptkbp:instance_of
|
gptkb:virus
|
gptkbp:associated_cancer
|
gptkb:Oncology
gptkb:nasopharyngeal_carcinoma
|
gptkbp:associated_with
|
gptkb:chronic_fatigue_syndrome
gptkb:systemic_lupus_erythematosus
gptkb:rheumatoid_arthritis
gptkb:multiple_sclerosis
lymphoproliferative disorders
|
gptkbp:author
|
gptkb:Michael_Epstein
gptkb:Bert_Achong
gptkb:Yvonne_Barr
|
gptkbp:complications
|
hepatitis
thrombocytopenia
splenic rupture
|
gptkbp:diagnosis
|
blood test
|
gptkbp:discovery
|
gptkb:United_Kingdom
|
gptkbp:discovery_year
|
gptkb:1964
|
gptkbp:diseases
|
gptkb:Oncology
gptkb:Burkitt_lymphoma
yes
infectious mononucleosis
|
gptkbp:epidemiology
|
ubiquitous in human populations
|
gptkbp:family
|
gptkb:Herpesviridae
|
gptkbp:full_name
|
gptkb:Epstein-Barr_virus
|
gptkbp:genus
|
gptkb:Lymphocryptovirus
|
gptkbp:has_been_restored
|
possible
|
gptkbp:hosts
|
gptkb:humans
|
https://www.w3.org/2000/01/rdf-schema#label
|
EBV
|
gptkbp:incubation_period
|
4 to 6 weeks
|
gptkbp:is_compared_to
|
over 90% in adults
|
gptkbp:is_vulnerable_to
|
no approved vaccine
|
gptkbp:originated_in
|
B cells
epithelial cells
|
gptkbp:prevalence
|
common worldwide
|
gptkbp:propagation_method
|
saliva
|
gptkbp:replaces
|
Burkitt lymphoma cells
|
gptkbp:research_focus
|
autoimmune diseases
cancer biology
vaccine development
|
gptkbp:seed_dispersal
|
double-stranded DNA
|
gptkbp:serological_markers
|
gptkb:EBNA-Ig_G
EA-Ig G
VCA-Ig G
VCA-Ig M
|
gptkbp:symptoms
|
fatigue
fever
sore throat
swollen lymph nodes
|
gptkbp:treatment
|
antivirals
supportive care
corticosteroids
exploring monoclonal antibodies
investigating antiviral therapies
studying immune modulation
|
gptkbp:viral_entry
|
via oral mucosa
|
gptkbp:viral_family
|
gptkb:Herpesviridae
|
gptkbp:viral_genus
|
gptkb:Lymphocryptovirus
|
gptkbp:viral_infection_type
|
latent and lytic phases
|
gptkbp:viral_latency
|
establishes lifelong infection
|
gptkbp:viral_replication
|
in B lymphocytes
|
gptkbp:bfsParent
|
gptkb:Epstein-Barr_virus
|
gptkbp:bfsLayer
|
5
|